Laurus Labs Share Price
(LAURUSLABS)
₹536.75
as on 04:01PM, 20 Feb 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -6.42 % |
3 Month Return | + 11.78 % |
1 Year Return | + 36.26 % |
Market Stats | |
Previous Close | ₹546.75 |
Open | ₹541.15 |
Volume | 17.91L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹29,483.63Cr |
P/E Ratio
147.37
PEG Ratio
640.75
Market Cap
₹29,483.63 Cr
P/B Ratio
5.02
EPS
3.12
Dividend Yield
0.2
Sector
Pharmaceuticals
ROE
5.41
based on 14 analysts
40.00%
Buy
13.33%
Hold
46.67%
Sell
Based on 14 analysts offering long term price targets for Laurus Labs. An average target of ₹526.5
Source: S&P Global Market Intelligence
Laurus Labs price forecast by 14 analysts
Downside of
High
₹720
Target
₹526.50
Low
₹293
Laurus Labs target price ₹526.5, a slight downside of -3.7% compared to current price of ₹536.75. According to 14 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Laurus Labs revenue growth forecast
Expected growth rate Q1, FY2027:48.55%
Forecast
Actual
Including amortisation and stock based compensations
Laurus Labs EPS growth forecast
EPS estimate Q1, FY2027:407.38%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Laurus Labs Ltd
Laurus Labs Faces Continued Decline Amid Market Trends - 14 Feb, 2025
Laurus Labs Continues Upward Trend with Analyst Buy - 06 Feb, 2025
Laurus Labs Stock Recommended for Bullish Trade - 03 Feb, 2025
Laurus Labs Stock Surges on US HIV Treatment Waiver - 30 Jan, 2025
Laurus Labs Shares Plummet Amid Aid Concerns - 27 Jan, 2025
Laurus Labs Reports Strong Q3 Results and Stock Surge - 24 Jan, 2025
Laurus Labs Subsidiary Receives FDA Observation - 22 Jan, 2025
Laurus Labs Shows Strong Support and Upward Potential - 21 Jan, 2025
Laurus Labs Ltd Gains for Third Straight Session - 20 Jan, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, 12.51 Cr → 92.3 Cr (in ₹), with an average increase of 57.7% per quarter
Promoter Holding Up
Promoters have increased holdings from 27.18% to 27.62% in Dec 2024 quarter
Revenue Rich
Revenue is up for the last 3 quarters, 1.19K Cr → 1.42K Cr (in ₹), with an average increase of 8.1% per quarter
Retail Holding Up
Retail Investor have increased holdings from 33.69% to 34.08% in Dec 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 133.8%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 23.6%
FII Holding Down
Foreign Institutions have decreased holdings from 26.08% to 25.56% in Dec 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 8.25% to 7.62% in Dec 2024 quarter
Price Dip
In the last 7 days, LAURUSLABS stock has moved down by -9.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 27.62% | 1.64 | |
Foreign Institutions | 25.56% | ||
Mutual Funds | 7.62% | ||
Retail Investors | 34.08% | 1.15 | |
Others | 5.12% | 6.74 |
Laurus Labs in the last 5 years
Lowest (16.96x)
March 28, 2023
Industry (51.87x)
February 19, 2025
Today (147.37x)
February 19, 2025
Highest (242.70x)
December 6, 2024
Laurus Labs Ltd’s net profit jumped 298.88% since last year same period to ₹92.30Cr in the Q3 2024-2025. On a quarterly growth basis, Laurus Labs Ltd has generated 365.22% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2024, Laurus Labs Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.15%.
Read More about DividendsBearish
Neutral
Bullish
Laurus Labs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
HOLD | ₹29,483.63 Cr | 104.16% | 0.67 | ₹168 Cr | ₹5,040 Cr | |
HOLD | ₹21,840.22 Cr | 12.28% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
HOLD | ₹56,694.14 Cr | 15.67% | 0.56 | ₹1,811 Cr | ₹12,667 Cr | |
BUY | ₹9,521.57 Cr | 9.92% | 0.64 | ₹119 Cr | ₹547 Cr | |
BUY | ₹3,805.61 Cr | 3.46% | 0.54 | ₹69 Cr | ₹571 Cr |
Organisation | Laurus Labs |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Laurus Labs Ltd share price today stands at ₹536.75, Open: ₹541.15, Previous Close: ₹546.75, High: ₹549.55, Low: ₹531.5, 52 Week High: ₹646.2, 52 Week Low: ₹373.1.
Laurus Labs Ltd is listed on NSE
Laurus Labs Ltd is listed on BSE
Today's traded volume of Laurus Labs Ltd(LAURUSLABS) is 17.91L.
Today's market capitalisation of Laurus Labs Ltd(LAURUSLABS) is ₹29483.63Cr.
Laurus Labs Ltd (LAURUSLABS) share price is ₹536.75. It is down -16.94% from its 52 Week High price of ₹646.2
Laurus Labs Ltd (LAURUSLABS) share price is ₹536.75. It is up 43.86% from its 52 Week Low price of ₹373.1
PE Ratio of Laurus Labs Ltd is 147.37
PE ratio = Laurus Labs Ltd Market price per share / Laurus Labs Ltd Earnings per share